Initial institutional experience with thoracoscopic assisted esophagectomy

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Esophageal carcinoma presents a significant surgical challenge.
• Open esophagectomy (OE) is a traditional approach with associated morbidity.
• Advancements in minimally invasive techniques offer potential benefits.

Purpose of the Study:

• To evaluate the initial clinical outcomes of thoracoscopic assisted esophagectomy (TAE) for esophageal cancer.
• To compare the efficacy and safety of TAE with open esophagectomy (OE).

Main Methods:

• Retrospective analysis of 14 patients undergoing TAE between January 2007 and June 2009.
• Comparison of outcomes with 18 patients who underwent OE during the same period.
• Data collected included operative time, blood loss, complications, lymph node yield, morbidity, and mortality.

Main Results:

• TAE procedures were longer (median 460 vs. 386 minutes) but associated with significantly less blood loss (250 mL vs. 500 mL).
• Respiratory complications were lower in the TAE group (14.3% vs. 27.8%).
• In-hospital mortality was reduced with TAE (7.1% vs. 16.7%), with similar overall morbidity (42.8% vs. 50%).

Conclusions:

• Thoracoscopic assisted esophagectomy (TAE) is a feasible and safe alternative for esophageal cancer treatment.
• TAE offers advantages in reduced blood loss, fewer respiratory complications, and lower mortality.
• Further research is warranted to explore long-term outcomes of TAE.